{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T03:27:05Z","timestamp":1795231625188,"version":"4.10.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7951","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,3,9]]},"DOI":"10.1038\/s41586-022-05692-z","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T12:03:55Z","timestamp":1675857835000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":160,"title":["TET2 guards against unchecked BATF3-induced CAR T cell expansion"],"prefix":"10.1038","volume":"615","author":[{"given":"Nayan","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeguo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8745-1079","authenticated-orcid":false,"given":"Judith","family":"Feucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-5083","authenticated-orcid":false,"given":"Richard","family":"Koche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9751-0677","authenticated-orcid":false,"given":"Anton","family":"Dobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2889-1397","authenticated-orcid":false,"given":"Jorge","family":"Mansilla-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4747-6391","authenticated-orcid":false,"given":"Julie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3548-9227","authenticated-orcid":false,"given":"Yingqian","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrude","family":"Gunset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9031-8025","authenticated-orcid":false,"given":"Michel","family":"Sadelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"5692_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/PPO.0000000000000032","volume":"20","author":"S Kakarla","year":"2014","unstructured":"Kakarla, S. & Gottschalk, S. CAR T cells for solid tumors: armed and ready to go? Cancer J. 20, 151\u2013155 (2014).","journal-title":"Cancer J."},{"key":"5692_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nature22395","volume":"545","author":"M Sadelain","year":"2017","unstructured":"Sadelain, M., Riviere, I. & Riddell, S. Therapeutic T cell engineering. Nature 545, 423\u2013431 (2017).","journal-title":"Nature"},{"key":"5692_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1056\/NEJMra1706169","volume":"379","author":"CH June","year":"2018","unstructured":"June, C. H. & Sadelain, M. Chimeric antigen receptor therapy. N. Engl. J. Med. 379, 64\u201373 (2018).","journal-title":"N. Engl. J. Med."},{"key":"5692_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.omtm.2018.12.009","volume":"12","author":"S Guedan","year":"2019","unstructured":"Guedan, S., Calderon, H., Posey, A. D. Jr & Maus, M. V. Engineering and design of chimeric antigen receptors. Mol. Ther. Methods Clin. Dev. 12, 145\u2013156 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"5692_CR5","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/eji.202049064","volume":"51","author":"A Globerson Levin","year":"2021","unstructured":"Globerson Levin, A., Riviere, I., Eshhar, Z. & Sadelain, M. CAR T cells: building on the CD19 paradigm. Eur. J. Immunol. 51, 2151\u20132163 (2021).","journal-title":"Eur. J. Immunol."},{"key":"5692_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip, M. et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature 545, 452\u2013456 (2017).","journal-title":"Nature"},{"key":"5692_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature 571, 211\u2013218 (2019).","journal-title":"Nature"},{"key":"5692_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrm3589","volume":"14","author":"WA Pastor","year":"2013","unstructured":"Pastor, W. A., Aravind, L. & Rao, A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 14, 341\u2013356 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"5692_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4049\/jimmunol.1700559","volume":"200","author":"SA Carty","year":"2018","unstructured":"Carty, S. A. et al. The loss of TET2 promotes CD8+ T cell memory differentiation. J. Immunol. 200, 82\u201391 (2018).","journal-title":"J. Immunol."},{"key":"5692_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","volume":"558","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558, 307\u2013312 (2018).","journal-title":"Nature"},{"key":"5692_CR11","doi-asserted-by":"publisher","first-page":"a026518","DOI":"10.1101\/cshperspect.a026518","volume":"7","author":"RL Bowman","year":"2017","unstructured":"Bowman, R. L. & Levine, R. L. TET2 in normal and malignant hematopoiesis. Cold Spring Harb. Perspect. Med. 7, a026518 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"5692_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12185-016-2122-z","volume":"105","author":"S Chiba","year":"2017","unstructured":"Chiba, S. Dysregulation of TET2 in hematologic malignancies. Int. J. Hematol. 105, 17\u201322 (2017).","journal-title":"Int. J. Hematol."},{"key":"5692_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nri778","volume":"2","author":"SM Kaech","year":"2002","unstructured":"Kaech, S. M., Wherry, E. J. & Ahmed, R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2, 251\u2013262 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"5692_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3567","volume":"14","author":"DL Farber","year":"2014","unstructured":"Farber, D. L., Yudanin, N. A. & Restifo, N. P. Human memory T cells: generation, compartmentalization and homeostasis. Nat. Rev. Immunol. 14, 24\u201335 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"5692_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"5692_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","volume":"19","author":"CU Blank","year":"2019","unstructured":"Blank, C. U. et al. Defining \u2018T cell exhaustion\u2019. Nat. Rev. Immunol. 19, 665\u2013674 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"5692_CR17","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41591-019-0564-6","volume":"25","author":"RG Majzner","year":"2019","unstructured":"Majzner, R. G. & Mackall, C. L. Clinical lessons learned from the first leg of the CAR T cell journey. Nat. Med. 25, 1341\u20131355 (2019).","journal-title":"Nat. Med."},{"key":"5692_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2020","unstructured":"Rafiq, S., Hackett, C. S. & Brentjens, R. J. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat. Rev. Clin. Oncol. 17, 147\u2013167 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"5692_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930\u2013935 (2009).","journal-title":"Science"},{"key":"5692_CR20","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau, F. et al. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 360, 2289\u20132301 (2009).","journal-title":"N. Engl. J. Med."},{"key":"5692_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMc091348","volume":"361","author":"A Tefferi","year":"2009","unstructured":"Tefferi, A., Lim, K. H. & Levine, R. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 361, 1117\u20131118 (2009).","journal-title":"N. Engl. J. Med."},{"key":"5692_CR22","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","volume":"33","author":"Y Watatani","year":"2019","unstructured":"Watatani, Y. et al. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia 33, 2867\u20132883 (2019).","journal-title":"Leukemia"},{"key":"5692_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","volume":"28","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z. et al. Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells. Cancer Cell 28, 415\u2013428 (2015).","journal-title":"Cancer Cell"},{"key":"5692_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","volume":"543","author":"J Eyquem","year":"2017","unstructured":"Eyquem, J. et al. Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection. Nature 543, 113\u2013117 (2017).","journal-title":"Nature"},{"key":"5692_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/leu.2017.203","volume":"32","author":"A Lollies","year":"2018","unstructured":"Lollies, A. et al. An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma. Leukemia 32, 92\u2013101 (2018).","journal-title":"Leukemia"},{"key":"5692_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","volume":"34","author":"M Nakagawa","year":"2018","unstructured":"Nakagawa, M. et al. Targeting the HTLV-I-regulated BATF3\/IRF4 transcriptional network in adult T cell leukemia\/lymphoma. Cancer Cell 34, 286\u2013297.e10 (2018).","journal-title":"Cancer Cell"},{"key":"5692_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25379-9","volume":"12","author":"HC Liang","year":"2021","unstructured":"Liang, H. C. et al. Super-enhancer-based identification of a BATF3\/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma. Nat. Commun. 12, 5577 (2021).","journal-title":"Nat. Commun."},{"key":"5692_CR28","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1083\/jcb.150.5.1199","volume":"150","author":"MV Gonzalez","year":"2000","unstructured":"Gonzalez, M. V. et al. Glucocorticoids antagonize AP-1 by inhibiting the activation\/phosphorylation of JNK without affecting its subcellular distribution. J. Cell Biol. 150, 1199\u20131208 (2000).","journal-title":"J. Cell Biol."},{"key":"5692_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.gene.2017.12.024","volume":"645","author":"RH Patil","year":"2018","unstructured":"Patil, R. H. et al. Dexamethasone inhibits inflammatory response via down regulation of AP-1 transcription factor in human lung epithelial cells. Gene 645, 85\u201394 (2018).","journal-title":"Gene"},{"key":"5692_CR30","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.celrep.2016.01.035","volume":"14","author":"GR Kafer","year":"2016","unstructured":"Kafer, G. R. et al. 5-Hydroxymethylcytosine marks sites of DNA damage and promotes genome stability. Cell Rep. 14, 1283\u20131292 (2016).","journal-title":"Cell Rep."},{"key":"5692_CR31","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.celrep.2018.10.028","volume":"25","author":"LL Chen","year":"2018","unstructured":"Chen, L. L. et al. SNIP1 recruits TET2 to regulate c-MYC target genes and cellular DNA damage response. Cell Rep. 25, 1485\u20131500.e4 (2018).","journal-title":"Cell Rep."},{"key":"5692_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn, R. C. et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature 576, 293\u2013300 (2019).","journal-title":"Nature"},{"key":"5692_CR33","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41590-021-00964-8","volume":"22","author":"H Seo","year":"2021","unstructured":"Seo, H. et al. BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells. Nat. Immunol. 22, 983\u2013995 (2021).","journal-title":"Nat. Immunol."},{"key":"5692_CR34","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/ni.2710","volume":"14","author":"K Man","year":"2013","unstructured":"Man, K. et al. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 14, 1155\u20131165 (2013).","journal-title":"Nat. Immunol."},{"key":"5692_CR35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","volume":"47","author":"K Man","year":"2017","unstructured":"Man, K. et al. Transcription factor IRF4 promotes CD8+ T cell exhaustion and limits the development of memory-like T cells during chronic infection. Immunity 47, 1129\u20131141.e5 (2017).","journal-title":"Immunity"},{"key":"5692_CR36","unstructured":"McCutcheon, S. et al. CRISPR-based epigenome editing screens in primary human T cells. Mol. Ther. 30, 165\u2013166 (2022)."},{"key":"5692_CR37","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41590-020-0786-2","volume":"21","author":"MA Ataide","year":"2020","unstructured":"Ataide, M. A. et al. BATF3 programs CD8+ T cell memory. Nat. Immunol. 21, 1397\u20131407 (2020).","journal-title":"Nat. Immunol."},{"key":"5692_CR38","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl, R. & Wagner, E. F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859\u2013868 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"5692_CR39","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1101\/gad.13.5.607","volume":"13","author":"M Schreiber","year":"1999","unstructured":"Schreiber, M. et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13, 607\u2013619 (1999).","journal-title":"Genes Dev."},{"key":"5692_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.49","volume":"3","author":"MR Logan","year":"2012","unstructured":"Logan, M. R., Jordan-Williams, K. L., Poston, S., Liao, J. & Taparowsky, E. J. Overexpression of Batf induces an apoptotic defect and an associated lymphoproliferative disorder in mice. Cell Death Dis. 3, e310 (2012).","journal-title":"Cell Death Dis."},{"key":"5692_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","volume":"20","author":"C Quivoron","year":"2011","unstructured":"Quivoron, C. et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25\u201338 (2011).","journal-title":"Cancer Cell"},{"key":"5692_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJMc1111708","volume":"366","author":"L Couronne","year":"2012","unstructured":"Couronne, L., Bastard, C. & Bernard, O. A. TET2 and DNMT3A mutations in human T-cell lymphoma. N. Engl. J. Med. 366, 95\u201396 (2012).","journal-title":"N. Engl. J. Med."},{"key":"5692_CR43","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ng.3610","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells. Nat. Genet. 48, 1014\u20131023 (2016).","journal-title":"Nat. Genet."},{"key":"5692_CR44","doi-asserted-by":"publisher","first-page":"e145459","DOI":"10.1172\/JCI145459","volume":"131","author":"W Kong","year":"2021","unstructured":"Kong, W. et al. BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia. J. Clin. Invest. 131, e145459 (2021).","journal-title":"J. Clin. Invest."},{"key":"5692_CR45","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","volume":"92","author":"I Riviere","year":"1995","unstructured":"Riviere, I., Brose, K. & Mulligan, R. C. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl Acad. Sci. USA 92, 6733\u20136737 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5692_CR46","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1182\/blood.V90.3.952","volume":"90","author":"HF Gallardo","year":"1997","unstructured":"Gallardo, H. F., Tan, C., Ory, D. & Sadelain, M. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90, 952\u2013957 (1997).","journal-title":"Blood"},{"key":"5692_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm827","volume":"9","author":"RJ Brentjens","year":"2003","unstructured":"Brentjens, R. J. et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat. Med. 9, 279\u2013286 (2003).","journal-title":"Nat. Med."},{"key":"5692_CR48","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1158\/1078-0432.CCR-07-0674","volume":"13","author":"RJ Brentjens","year":"2007","unstructured":"Brentjens, R. J. et al. Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts. Clin. Cancer Res. 13, 5426\u20135435 (2007).","journal-title":"Clin. Cancer Res."},{"key":"5692_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.neo.7900018","volume":"1","author":"MC Gong","year":"1999","unstructured":"Gong, M. C. et al. Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen. Neoplasia 1, 123\u2013127 (1999).","journal-title":"Neoplasia"},{"key":"5692_CR50","doi-asserted-by":"publisher","first-page":"177ra138","DOI":"10.1126\/scitranslmed.3005930","volume":"5","author":"RJ Brentjens","year":"2013","unstructured":"Brentjens, R. J. et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci. Transl Med. 5, 177ra138 (2013).","journal-title":"Sci. Transl Med."},{"key":"5692_CR51","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/nm1676","volume":"13","author":"MT Stephan","year":"2007","unstructured":"Stephan, M. T. et al. T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nat. Med. 13, 1440\u20131449 (2007).","journal-title":"Nat. Med."},{"key":"5692_CR52","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.4049\/jimmunol.177.9.6072","volume":"177","author":"TA Stoklasek","year":"2006","unstructured":"Stoklasek, T. A., Schluns, K. S. & Lefrancois, L. Combined IL-15\/IL-15R\u03b1 immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 177, 6072\u20136080 (2006).","journal-title":"J. Immunol."},{"key":"5692_CR53","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"5692_CR54","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1089\/104303401750148649","volume":"12","author":"M Schmidt","year":"2001","unstructured":"Schmidt, M. et al. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum. Gene Ther. 12, 743\u2013749 (2001).","journal-title":"Hum. Gene Ther."},{"key":"5692_CR55","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/nm.2057","volume":"15","author":"R Gabriel","year":"2009","unstructured":"Gabriel, R. et al. Comprehensive genomic access to vector integration in clinical gene therapy. Nat. Med. 15, 1431\u20131436 (2009).","journal-title":"Nat. Med."},{"key":"5692_CR56","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/nprot.2010.87","volume":"5","author":"A Paruzynski","year":"2010","unstructured":"Paruzynski, A. et al. Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat. Protoc. 5, 1379\u20131395 (2010).","journal-title":"Nat. Protoc."},{"key":"5692_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtn.2016.12.001","volume":"6","author":"S Afzal","year":"2017","unstructured":"Afzal, S., Wilkening, S., von Kalle, C., Schmidt, M. & Fronza, R. GENE-IS: time-efficient and accurate analysis of viral integration events in large-scale gene therapy data. Mol. Ther. Nucleic Acids 6, 133\u2013139 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"5692_CR58","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"5692_CR59","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403\u2013410 (1990).","journal-title":"J. Mol. Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05692-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T15:31:31Z","timestamp":1679844691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05692-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":59,"journal-issue":{"issue":"7951","published-print":{"date-parts":[[2023,3,9]]}},"alternative-id":["5692"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-05692-z","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"21 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}